ADIA Nutrition, Inc. Q1 2026 Financial Report: Key Highlights and Shareholder Update
ADIA Nutrition, Inc. (the “Company”) has released its Quarterly Report on Form 10-Q for the period ended March 31, 2026, providing investors with a detailed look at its financial performance, balance sheet, and operational status. Below is an in-depth summary of the most critical points, including items that may be price sensitive and relevant to shareholders.
1. Key Financial Highlights
- Total Assets: The Company reported total assets of \$776,868 as of March 31, 2026, up from \$594,826 at December 31, 2025. This represents a significant increase, largely due to a rise in current assets and a notable investment in a non-consolidated entity (\$79,500).
- Cash Position: Cash and cash equivalents stood at \$136,716, up from \$45,991 at the end of 2025. This improvement in liquidity is a positive signal to investors.
- Current Assets: Current assets increased to \$358,907 from \$161,510, indicating improved short-term financial health.
- Liabilities: Total liabilities decreased sharply to \$1,197,067 from \$852,500 at year-end 2025. This jump may indicate new borrowings or obligations, and investors should monitor future filings for clarification.
- Stockholders’ Equity (Deficit): The Company reported a stockholders’ deficit of (\$420,199) as of March 31, 2026, worsening from (\$257,674) at December 31, 2025. This negative equity position is a major concern for shareholders and could affect market sentiment.
- Net Loss: For the three months ended March 31, 2026, ADIA Nutrition posted a net loss of \$162,525, compared to a net loss of \$116,219 for the same period in 2025. This widening loss could be price sensitive, especially as it reflects operational challenges or increased expenses.
- Shares Outstanding: As of May 15, 2026, there were 94,404,696 shares of common stock outstanding, par value \$0.001 per share.
- Net Loss Per Share: The net loss per share was \$0.00 for both basic and diluted, reflecting the large number of shares outstanding and the net loss.
- Weighted Average Shares Outstanding: The weighted average number of shares for the quarter was 94,404,696 (Q1 2026) and 95,899,861 (Q1 2025).
2. Operational and Regulatory Status
- Reporting Compliance: The Company confirmed it has filed all required reports and submitted all interactive data files as per SEC requirements.
- Filer Status: ADIA Nutrition is classified as a Smaller Reporting Company and not an Emerging Growth Company. It is also not a shell company.
- No Trading Symbol: The Company’s shares are not listed on any exchange, and there is no trading symbol provided.
- Series A & Series C Preferred Stock: Both Series A and Series C Preferred Stock remain unchanged with 10,000,000 and 1,750,000 shares respectively issued and outstanding, par value \$0.001. No new issuances or conversions were reported.
3. Items That May Affect Share Value
- Worsening Stockholders’ Deficit: The Company’s deficit increased significantly during the quarter, which may negatively affect investor confidence and share price if not addressed by management.
- Operational Losses: The continued and increasing net losses are a red flag for investors, indicating ongoing challenges in achieving profitability.
- Liquidity Improvement: The improved cash position is a positive, but offset by the worsening deficit and losses.
- Investment in Non-Consolidated Entity: The Company invested \$79,500 in another entity, the details of which could influence future strategic direction and risk profile.
- No Change in Preferred Stock or New Equity Issuance: The capital structure remains largely unchanged. No new equity has been issued, and no preferred shares have been converted or redeemed.
- Shares to Be Issued: The line item “Shares to be issued” remains at \$152,607 for both March 31, 2026 and December 31, 2025; this may suggest pending equity transactions or compensation, potentially dilutive to existing shareholders.
4. Forward-Looking Statements and Risks
The Company warns that its forward-looking statements are subject to risks and uncertainties, many outside its control. These include operational risks, financial risks, and uncertainties regarding investments and capital structure. Shareholders are advised to review the “Risk Factors” section in the Company’s Annual Report for further details.
5. Financial Statements Overview
- Condensed Consolidated Balance Sheets: Provides a snapshot of assets, liabilities, and equity as of March 31, 2026, and December 31, 2025.
- Condensed Consolidated Statements of Operations: Details revenue, expenses, and net loss for Q1 2026 and Q1 2025.
- Condensed Consolidated Statements of Stockholders’ Deficit: Outlines changes in equity, including preferred and common stock balances, additional paid-in capital, and accumulated deficit.
- Condensed Consolidated Statements of Cash Flows: Shows cash movements during the quarter, highlighting operational, investing, and financing activities.
6. Newsworthy Conclusion for Investors
ADIA Nutrition, Inc. appears to be facing continued financial difficulties, as evidenced by its growing net loss and deepening stockholders’ deficit. While its cash position has improved, the negative equity and ongoing losses are key risks that could impact future share value and investor sentiment. The investment in a non-consolidated entity may signal potential future strategic moves, but the lack of further detail means investors should monitor future filings closely.
Potential Price Sensitivities:
- Increasing net losses and worsening deficit may depress share values.
- Improved liquidity provides some relief but is overshadowed by negative equity.
- Pending “shares to be issued” may dilute existing holdings.
- Investment in non-consolidated entity could be positive or negative, depending on future developments.
Disclaimer: This article is for informational purposes only. It does not constitute investment advice or a recommendation to buy or sell any securities. Investors should conduct their own due diligence and consult with their financial advisors before making any investment decisions. All information is based on the Company’s public filings and is subject to change without notice.
